Model Number 106524US |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Stroke/CVA (1770); Hemorrhage, Subarachnoid (1893)
|
Event Date 07/22/2020 |
Event Type
Injury
|
Manufacturer Narrative
|
No further information was provided.A supplemental report will be submitted when the manufacturer¿s investigation is completed.
|
|
Event Description
|
It was reported that patient had stroke following lvad implant on (b)(6)2020 in the left cerebral hemisphere area.Patient presented at that time with aphasia.Additional information states that patient had an ischemic stroke, the anticoagulation was held peri/post operatively.Ct scan was performed.Patient had aphasia post-extubating.Resumption delayed due to concern for hemorrhagic conversion.Anticoagulation resumed without incident on post operative day 4.A serial head ct and neuro exams stable from time of incident to time of resumption.
|
|
Event Description
|
It was later reported that the patient also had a subarachnoid hemorrhage.The patient was immediately post-implant at the time of the initial cerebrovascular accident (cva).The patient had a head computed tomography (ct) scan.The patient was aphasic after extubation following surgical implant.The patient underwent serial ct scans and was treated with conservative anticoagulation.There was no surgical intervention.No additional information was provided.
|
|
Manufacturer Narrative
|
Manufacturer's investigation conclusion: a direct relationship between heartmate 3 lvas, serial number (b)(6), and the reported events could not be conclusively established through this evaluation.The patient remained ongoing on heartmate 3 lvas, serial number (b)(6) until they ultimately expired on (b)(6) 2020 (addressed under mfr # 2916596-2020-05264).No product is available for investigation.The relevant sections of the device history records for (b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specifications.The implant kit was shipped to the customer on (b)(6) 2020.The heartmate 3 lvas ifu lists stroke, bleeding and other neurological events (not stroke-related) as adverse events that may be associated with the use of heartmate 3 left ventricular assist system.Additionally, section 6 lists neurologic dysfunction as a potential late postimplant complication that may be associated with the use of heartmate 3 left ventricular assist system.This section also contains information regarding the recommended anticoagulation therapy and inr range.No further information was provided.The manufacturer is closing this event.
|
|
Search Alerts/Recalls
|